Polaris Group Announces Treatment of First Patient in Phase 1 Clinical Trial of ADI-PEG 20 plus Pemetrexed and Cisplatin
News
The Polaris Group is currently conducting clinical trials of ADI-PEG 20 to improve response rate to the combination pemetrexed and cisplatin in the treatment of Malignant Pleural Mesothelioma (MPM) and ... Read more